輕型肝性腦病患者腦電圖與臨床相關(guān)指標的相關(guān)性
[Abstract]:Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome. It is characterized by cognition, behavior and dysfunction. It is associated with liver failure and portosystemic shunt. The main manifestations are disturbance of consciousness, abnormal behavior, and coma.HE, which are acute and slow liver diseases, and are fatal complications, such as untimely correction, The pathogenesis of hepatic encephalopathy is currently recognized as ammonia poisoning theory, the formation and metabolism of blood ammonia determine the progression of hepatic encephalopathy, the treatment is mainly to relieve the HE inducement and blood ammonia treatment to achieve clinical cure. According to the patient's mental condition, clinical index and general consciousness change, HE It is divided into 0-4 stages, five periods (West Haven staging), from mild mental change to deep coma, of which 0 is MHE, and MHE refers to cirrhosis patients with no abnormal clinical examination, but neuropsychological and neurophysiological injuries occur. If MHE does not intervene and treat in time, it may eventually develop into OHE. clinical OHE through symptoms, signs and blood. Laboratory diagnosis of ammonia, such as MHE, is not difficult to diagnose. The misdiagnosis of the clinical manifestations of the nervous system is easy to be missed. The misdiagnosed.MHE has not yet a unified diagnostic standard. The diagnostic HE method with high sensitivity and specificity is needed in clinic. Because of the lack of typical clinical manifestations, MHE can only be found by the psychologic test and neuropsychological test. Age, education, learning, memory, and different cultural backgrounds, the influence of race and patient cooperation should not be used alone as a screening tool for MHE. In order to solve these shortcomings, Van der Rijt et al. Proposed the electroencephalogram spectrum analysis, and took the lead to point out that spectral analysis can be used as an indicator of the diagnosis and prognosis of HE because the electroencephalogram is not subject to complex education. The electroencephalogram has been proved to be a sensitive and independent HE monitoring tool. Objective: To explore the clinical value of electroencephalogram in patients with light hepatic encephalopathy. Objective: To explore the clinical value of electroencephalogram examination in patients with light hepatic encephalopathy. Materials and methods: electroencephalogram examination was carried out in 41 patients with light hepatic encephalopathy, and the sensitivity of electroencephalogram V was observed and the sensitivity of HE was observed and the sensitivity of electroencephalogram was observed. Specificity. 41 cases of light hepatic encephalopathy were divided into A, B, and 3 groups according to the liver function Child-pugh classification, and divided into 2 groups according to the typical clinical signs of hepatic encephalopathy, and divided into 5 groups according to the clinical related indexes. Results: (1) there were 36 cases of liver cirrhosis, 87.80%, and 41 cases of light liver disease. (2) 41 cases of light liver. The mild abnormality of EEG in patients with sexual encephalopathy was 9 (21.95%), mild abnormality in 27 cases (65.85%), moderate abnormality in 5 cases (12.20%); (3) 41 cases of light hepatic encephalopathy were divided into A, B, C three, group A, 8 cases, B group 12, C group 21, there was no significant difference between B group and C group, A group and B group, significant difference; 4) ratio There was no significant difference in electroencephalogram abnormalities between the 1.2 groups and the 1.2 groups; the total bilirubin less than 34.2 groups and the 34.2 groups had no significant difference in electroencephalogram. The differences of abnormal EEG differences between the 30 groups and the 30 groups were significant, and the difference between the mild electroencephalogram and the mild electroencephalogram was significant; (5) group PTA80 and < 80, group PTA40 There was no significant difference in electroencephalogram abnormalities between the 40 groups and the 40 groups. (6) there was no significant difference in electroencephalogram abnormalities between the group of blood ammonia > 60 and the 60 groups. There was no significant difference in electroencephalogram abnormalities between the groups of blood ammonia 120 and the 120 groups. (7) there was a significant difference between the HE clinical sign group and the non HE clinical sign group, in which the slight HE and the light HE were compared to the abnormal electroencephalogram. Conclusion: (1) slight abnormal EEG can be found in mild hepatic encephalopathy; (2) the abnormal degree of electroencephalogram is positively correlated with the classification of hepatic encephalopathy; (3) the electroencephalogram examination is practical and easy to operate. It can be used as a diagnostic tool for light hepatic encephalopathy, and can be more widely used in clinic to improve the light liver nature. The diagnostic rate of encephalopathy, especially for mild hepatic encephalopathy.
【學位授予單位】:吉林大學
【學位級別】:碩士
【學位授予年份】:2016
【分類號】:R575.3
【相似文獻】
相關(guān)期刊論文 前10條
1 邵麗華,孫淑愛,郭冬梅,王淑娥,岳鳳娥,趙麗,馬立憲;肝性腦病患者血清一氧化氮水平的研究[J];山東醫(yī)科大學學報;2001年02期
2 黃克力,石振友,張振寧;醫(yī)源性肝性腦病66例報告[J];山東醫(yī)藥;2002年22期
3 周利民;肝性腦病24例臨床分析[J];瀘州醫(yī)學院學報;2002年03期
4 章景賢,向軍,余湊水,黃文勁;單純脾切除所致肝性腦病2例[J];中國血吸蟲病防治雜志;2002年04期
5 江虹;肝性腦病33例臨床研究[J];中國微生態(tài)學雜志;2002年06期
6 劉衛(wèi),朱斌,章福彬,許邦福;肝性腦病180例原因分析[J];實用肝臟病雜志;2004年02期
7 盛吉芳;肝性腦病的治療[J];中華肝臟病雜志;2004年05期
8 曹世忠,馬宏杰;肝性腦病的腦干聽覺誘發(fā)電位58檢測分析[J];山東醫(yī)藥;2004年31期
9 李瑜元;;肝性腦病研究中的失誤和探討[J];中華醫(yī)學雜志;2005年38期
10 王宇,樸云峰,許賢姬;肝性腦病的研究進展[J];臨床肝膽病雜志;2005年02期
相關(guān)會議論文 前10條
1 曹榮;胡旭東;阮連國;程海林;李宏杰;徐德翠;黃少平;;瑞苷治療肝性腦病32例療效觀察[A];全國第2屆中西醫(yī)結(jié)合傳染病學術(shù)會議暨國家中醫(yī)藥管理局第1屆傳染病協(xié)作組會議論文匯編[C];2008年
2 李政育;;由肝性腦病的臨床談臺灣地區(qū)肝性腦病的治療原則[A];第四次全國中西醫(yī)結(jié)合神經(jīng)系統(tǒng)疾病學術(shù)研討會論文集[C];2002年
3 趙和平;丁保華;張建設(shè);郭世民;張自然;趙耀州;;結(jié)腸凈化對肝性腦病干預(yù)的臨床研究[A];第一屆全國疑難重型肝病大會、第四屆全國人工肝及血液凈化學術(shù)年會論文集[C];2008年
4 盛吉芳;;肝性腦病診治[A];中華醫(yī)學會第十六次全國病毒性肝炎及肝病學術(shù)會議論文匯編[C];2013年
5 劉玉蘭;;中國肝性腦病診治共識[A];2013第六屆浙江省消化病學術(shù)大會論文匯編[C];2013年
6 蘭晶;;中西醫(yī)結(jié)合治療肝性腦病20例[A];第二十一屆全國中西醫(yī)結(jié)合消化系統(tǒng)疾病學術(shù)會議暨國家級中西醫(yī)結(jié)合消化系統(tǒng)疾病新進展學習班論文匯編[C];2009年
7 劉寶華;;肝性腦病患者的預(yù)見性觀察與護理[A];中華中醫(yī)藥學會脾胃病分會第十九次全國脾胃病學術(shù)交流會論文匯編[C];2007年
8 祝勝美;馮慧悅;;腦電雙頻指數(shù)用于肝性腦病診斷的研究[A];2009年浙江省麻醉學學術(shù)會議論文匯編[C];2009年
9 程井軍;伊藤一健;山本西司;;核因子-κB與肝性腦病關(guān)系探討[A];全國第2屆中西醫(yī)結(jié)合傳染病學術(shù)會議暨國家中醫(yī)藥管理局第1屆傳染病協(xié)作組會議論文匯編[C];2008年
10 李汾香;;中西醫(yī)結(jié)合治療肝性腦病57例療效觀察[A];中華中醫(yī)藥學會全國第十四次肝膽病學術(shù)會議論文匯編[C];2010年
相關(guān)重要報紙文章 前10條
1 錢亮;易與肝性腦病混淆的疾病[N];農(nóng)村醫(yī)藥報(漢);2009年
2 ;患肝性腦病是何病因[N];醫(yī)藥養(yǎng)生保健報;2005年
3 ;肝性腦病的診斷要點[N];農(nóng)村醫(yī)藥報(漢);2007年
4 劉英;預(yù)見性護理防肝性腦病[N];醫(yī)藥養(yǎng)生保健報;2006年
5 高翔;肝性腦病的診斷[N];農(nóng)村醫(yī)藥報(漢);2009年
6 ;肝性腦病的治療[N];農(nóng)村醫(yī)藥報(漢);2007年
7 首都醫(yī)科大學附屬北京天壇醫(yī)院消化內(nèi)科 李瑞軍;中藥提取物水蘇糖對肝性腦病具有預(yù)防作用[N];中國食品報;2009年
8 魏瑋 陳軍梅 張赤志;乳黃制劑可預(yù)防肝性腦病[N];中國醫(yī)藥報;2005年
9 劉汶 肖e,
本文編號:2161169
本文鏈接:http://sikaile.net/yixuelunwen/xiaohjib/2161169.html